查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球 DNA 定序市場評估，按產品類型、技術、應用、最終用戶、地區、機會和預測（2017-2031 年）
市場調查報告書
商品編碼
1408042

全球 DNA 定序市場評估，按產品類型、技術、應用、最終用戶、地區、機會和預測（2017-2031 年）

Global DNA Sequencing Market Assessment, By Product Type, By Technology, By Application, By End-users, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 224 Pages | 商品交期: 3-5個工作天內

價格

全球 DNA 定序市場規模預計在 2023 年將達到 81.6 億美元，在 2031 年將達到 245.1 億美元，在 2024-2031 年預測期內複合年增長率為 14.74%。 囊性纖維化等慢性疾病和其他遺傳性疾病可以透過DNA定序進行高精度診斷，增加了市場需求。 越來越多的基因研究人員用於藥物開發、農業研究和法醫學等各種目的，創造了對 DNA 定序產品的巨大需求，進一步推動了市場的發展。 技術進步和政府對科學研究和開發的支持預計將在市場發展中發揮關鍵作用。 然而，與產品相關的高成本、缺乏高技能專業人員以及複雜的數據解釋正在限制市場的成長。

慢性病和遺傳疾病的盛行率不斷上升

慢性病和遺傳病患疾病率的增加是 DNA 定序市場的關鍵驅動因素。 癌症、心血管疾病和其他慢性疾病的發生率和盛行率不斷上升，刺激了對基於 DNA 定序的診斷的需求並推動市場成長。 DNA定序在這些疾病的診斷和治療中發揮重要作用，導致對相關產品和服務的需求增加。 DNA 定序技術能夠識別特定疾病標記並預測個體對治療的反應，這正在推動其採用並進一步促進市場擴張。 根據世界衛生組織 2023 年 9 月的說明書，非傳染性疾病 (NCD) 每年導致 4,100 萬人死亡，佔全球死亡人數的 74%。 約 1700 萬人在 70 歲時死於非傳染性疾病，其中 86% 發生在低收入和中等收入國家。 大多數非傳染性疾病死亡是由心血管疾病（CVD）引起的，其次是癌症、慢性呼吸道疾病和糖尿病。

不斷發展的研發

探索基因組並將其利潤用於各種目的的研究和開發的成長正在對市場產生積極影響。 在過去的幾十年裡，人類基因組計畫為擴大研究領域（包括基因組探索）做出了重大貢獻。 同時，由於學術/組織研究計畫中對桑格技術和NGS的接受和利用不斷增加，市場預計將出現顯著增長。

北美引領 DNA 定序市場

由於研發活動的高投資、主要參與者的技術開發以及先進的醫療基礎設施，美國和加拿大等北美國家預計將以最高的價值份額主導市場。 政府對各種 DNA 定序技術的支援活動正在推動該地區的市場成長。

新冠肺炎 (COVID-19) 的影響

COVID-19 大流行對市場產生了重大影響。 與 COVID-19 相關的護理的優先順序增加了 DNA 定序方法的使用來對抗這種病毒，同時減少了其他方法的使用。 新一代定序方法引起了人們對 COVID-19 診斷的極大興趣。 2021 年 COVID-19 患者的增加顯著增加了對包括 DNA 定序在內的診斷產品的需求，推動了市場成長。 此外，疫情對DNA定序市場的供應鏈產生了負面影響，在一定程度上抑制了成長，但在疫情限制解除後，市場很快就恢復了正常節奏，並在預測期內實現了穩定成長。預計會被記錄。

本報告研究和分析了全球 DNA 定序市場，提供市場規模和預測、市場動態以及主要參與者的現狀和前景。

目錄

第一章研究方法

第 2 章專案範圍與定義

第三章 COVID-19 對全球 DNA 定序市場的影響

第 4 章執行摘要

第五章全球 DNA 定序市場展望（2017-2031）

  • 市場規模與預測
    • 金額
    • 數量
  • 依產品類型
    • 消耗品
    • 設備
    • 服務
  • 按技術
    • 桑格定序
    • 次世代定序
    • 其他定序技術
  • 依用途
    • 診斷用途
    • 個人化醫療
    • 研究用途
  • 按最終用戶
    • 醫院、醫療機構
    • 學術研究機構
    • 製藥公司、生技公司
    • 其他
  • 按地區
    • 北美
    • 歐洲
    • 亞太地區
    • 南美洲
    • 中東/非洲
  • 市佔率：依公司劃分（2023 年）

第 6 章全球 DNA 定序市場展望：按地區劃分（2017-2031 年）

  • 北美
    • 市場規模與預測
    • 依產品類型
    • 按技術
    • 依用途
    • 按最終用戶
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 義大利
    • 英國
    • 俄羅斯
    • 荷蘭
    • 西班牙
    • 土耳其
    • 波蘭
  • 南美洲
    • 巴西
    • 阿根廷
  • 亞太地區
    • 印度
    • 中國
    • 日本
    • 澳大利亞
    • 越南
    • 韓國
    • 印尼
    • 菲律賓
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第 7 章市場地圖（2023 年）

  • 依類型
  • 按技術
  • 依用途
  • 按最終用戶
  • 按地區

第八章宏觀環境與產業結構

  • 需求與供給分析
  • 進出口分析 - 數量與價值
  • 供應/價值鏈分析
  • PESTEL 分析
  • 波特五力分析

第 9 章市場動態

  • 生長促進因素
  • 抑製成長的因素（問題、限制因素）

第 10 章監理架構與創新

  • 臨床試驗
  • 專利情況
  • 監理機關的核准
  • 創新/新技術

第十一章主要公司狀況

  • 前 5 名市場領導者的競爭矩陣
  • 前 5 位市場領導者的市場收入分析（2023 年）
  • 併購/合資企業（如果適用）
  • SWOT 分析（5 家公司進入市場）
  • 專利分析（如果適用）

第十二章價格分析

第 13 章案例研究

第14章主要公司展望

  • Illumina, Inc.
  • Thermo-Fischer scientific
  • BGI genomics
  • Agilent Technologies Inc.
  • 10X Genomics
  • QIAGEN
  • F. Hoffmann-La Roche Ltd
  • Merck KGaA
  • PerkinElmer Inc.
  • Myriad Genetics Inc.

第 15 章策略建議

第16章關於我們公司，免責聲明

Product Code: MX10838

Global DNA sequencing market size was valued at USD 8.16 billion in 2023, which is expected to reach USD 24.51 billion in 2031, with a CAGR of 14.74% for the forecast period between 2024 and 2031F. The global DNA sequencing market is a highly dynamic and promising market with a robust product and favorable market strategies. Healthcare professionals can diagnose chronic diseases with pinpoint accuracy which can facilitate the drafting of effective treatment and disease management strategies. Genetic mutation leading to chronic disease can be detected early using DNA sequencing. Several chronic diseases and other genetic disorders like cystic fibrosis are diagnosed using DNA sequencing with high precision, thus there is a growing demand for the market. The increasing number of genetic researchers for different purposes, like drug development, agricultural research, and forensics, creates a huge demand for DNA sequencing products, further driving the market. Technological advancements and government support for scientific research and development are expected to play a pivotal role in developing the market. However, the high cost associated with products, the lack of highly skilled professionals, and the interpretation of complicated data are some of the hindrances in the growth of the global DNA sequencing market.

In September 2023, Integrated DNA Technologies (IDT), announced the launch of xGen NGS products designed exclusively for the Ultima Genomics UG 100™ platform. The launch package of new xGen NGS tools comprised of adapters, primers, and universal blockers. It can support a wide range of applications, including DNA, RNA, and methylation sequencing workflows. The xGen NGS aims to minimize the possible errors in sequencing, thus improving overall outcomes.

Growing Prevalence of Chronic Diseases and Genetic Disorders

The growing prevalence of chronic diseases and genetic disorders is a significant driver of the DNA sequencing market. The increasing incidence and prevalence of cancer, cardiovascular diseases, and other chronic ailments are fueling the demand for DNA sequencing-based diagnosis, driving market growth. DNA Sequencing plays a substantial role in the diagnosis and treatment of these diseases, leading to a rising demand for related products and services. The ability of DNA sequencing techniques to identify specific disease markers and predict individual responses to treatments is driving their adoption, further contributing to market expansion. In September 2023, according to a factsheet by WHO, noncommunicable diseases (NCDs) are responsible for killing 41 million people each year, equivalent to 74% of all deaths globally. Around 17 million people die from an NCD before the age of 70 years; 86% of these premature deaths occur in low- and middle-income countries. Cardiovascular diseases (CVDs) account for most NCD deaths, (17.9 million people annually), followed by cancers (9.3 million), chronic respiratory diseases (4.1 million), and diabetes (2.0 million).

Growing Research and Development

Growing research and development around genome exploration and utilizing its benefits for several purposes is positively impacting the global DNA sequencing market. The human genome project contributed a lot in the past few decades to the increasing research environment involving genome expeditions. Along with that, increased acceptance, and usage of sanger technology and NGS in academic and institutional research projects, the market is expected to register significant growth. In November 2023, UK Biobank Limited released the world's largest-by-far single set of sequencing data in the public domain after consistent research for five years with an investment of EUR 200 million. The data is set to drive the discovery of novel diagnostics, treatments, and cures. The data is available to approved researchers worldwide, via a protected database containing only de-identified data.

Sanger Sequencing is Expected to Dominate During Forecast Period

Sanger sequencing is considered as a standard for accurate detection of single nucleotide variants and small insertions/deletions, thus it is usually preferred over other sequencing methods. With the increasing use of sanger sequencing, this segment is expected to dominate the technology category in the DNA sequencing market throughout the forecast period. Various market players are dedicated to providing better DNA sequencing services and expanding their market. In June 2023, Source Genomics, a subsidiary of Source BioScience group, announced the opening of its new laboratory in the North of England which aims to provide improved Sanger sequencing services to the northern region of England with faster turnaround time.

North America to Lead the DNA Sequencing Market

With high investment in research and development activities, technological advancements by key players, and highly advanced healthcare infrastructure in North American countries, like the United States and Canada, are expected to dominate the market with the highest value share. The supportive government initiatives for different DNA sequencing techniques are embracing the growth of market in the region. In May 2023, The National Institutes of Health (NIH) launched a new program, the Common Fund's Somatic Mosaicism Across Human Tissues (SMaHT) Network worth USD 140 million to explore knowledge about genetic variation in normal human cells and tissues.

Impact of COVID-19

The COVID-19 pandemic had a significant impact on DNA Sequencing market. The prioritization of COVID-19-related care led to an increase in the use of DNA sequencing methods for addressing the virus but simultaneously reduced other applications. Next-generation sequencing methods gained huge interest in the diagnosis of COVID-19. Rising COVID-19 cases in the year 2021 significantly boosted the demand for diagnostic products involving DNA sequencing, propelling the market growth. Furthermore, the pandemic negatively influenced the supply chain in the DNA Sequencing market, limiting the growth to some extent, but the market resumed to its usual pace soon after the pandemic restrictions were waived off and is expected to register consistent growth during the forecast period.

Key Players Landscape and Outlook

To increase their presence globally, major companies in the market are undertaking strategies such as product launches, mergers and acquisitions, and partnerships. In October 2022, PacBio announced the launch of their two new sequencing platforms, Revio and Onso. Revio is a short-read sequencing system while Onse is a long-read DNA sequencing platform for improving the sequencing outcomes of researchers. The Revio System has a U.S. list price of USD 779,000 while Onso has a U.S. list price of USD 259,000.

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Impact of COVID-19 on Global DNA Sequencing Market

4. Executive Summary

5. Global DNA Sequencing Market Outlook, 2017-2031F

  • 5.1 Market Size & Forecast
    • 5.1.1. By Value
    • 5.1.2. By Volume
  • 5.2. By Product Type
    • 5.2.1. Consumables
    • 5.2.2. Instruments
    • 5.2.3. Services
  • 5.3. By Technology
    • 5.3.1. Sanger Sequencing
    • 5.3.2. Next-Generation Sequencing
    • 5.3.3. Other Sequencing Technologies
  • 5.4. By Application
    • 5.4.1. Diagnostic Applications
    • 5.4.2. Personalized Medicine
    • 5.4.3. Research Applications
      • 5.4.3.1. Forensics
      • 5.4.3.2. Agriculture
      • 5.4.3.3. Drug Development
      • 5.4.3.4. Others
  • 5.5. By End-users
    • 5.5.1 Hospitals and Healthcare Organizations
    • 5.5.2 Academics and Research Institutions
    • 5.5.3 Pharmaceutical and Biotechnology Companies
    • 5.5.4 Others
  • 5.6 By Region
    • 5.6.1 North America
    • 5.6.2 Europe
    • 5.6.3 Asia Pacific
    • 5.6.4 South America
    • 5.6.5 Middle East & Africa
  • 5.7 By Company Market Share (%), 2023

6. Global DNA Sequencing Market Outlook, By Region, 2017-2031F

  • 6.1. North America
    • 6.1.1. Market Size & Forecast
      • 6.1.1.1. By Value
      • 6.1.1.2. By Volume
    • 6.1.2. By Product Type
      • 6.1.2.1. Consumables
      • 6.1.2.2. Instruments
      • 6.1.2.3. Services
    • 6.1.3. By Technology
      • 6.1.3.1. Sanger Sequencing
      • 6.1.3.2. Next-Generation Sequencing
      • 6.1.3.3. Other Sequencing Technologies
    • 6.1.4. By Application
      • 6.1.4.1. Diagnostic Applications
      • 6.1.4.2. Personalized Medicine
      • 6.1.4.3. Research Applications
      • 6.1.4.3.1. Forensics
      • 6.1.4.3.2. Agriculture
      • 6.1.4.3.3. Drug Development
      • 6.1.4.3.4. Others
    • 6.1.5. By End-users
      • 6.1.5.1. Hospitals and Healthcare Organizations
      • 6.1.5.2. Academics and Research Institutions
      • 6.1.5.3. Pharmaceutical and Biotechnology Companies
      • 6.1.5.4. Others
    • 6.1.6. United States*
      • 6.1.6.1. Market Size & Forecast
      • 6.1.6.1.1. By Value
      • 6.1.6.1.2. By Volume
      • 6.1.6.2. By Product Type
      • 6.1.6.2.1. Consumables
      • 6.1.6.2.2. Instruments
      • 6.1.6.2.3. Services
      • 6.1.6.3. By Technology
      • 6.1.6.3.1. Sanger Sequencing
      • 6.1.6.3.2. Next-Generation Sequencing
      • 6.1.6.3.3. Other Sequencing Technologies
      • 6.1.6.4. By Application
      • 6.1.6.4.1. Diagnostic Applications
      • 6.1.6.4.2. Personalized Medicine
      • 6.1.6.4.3. Research Applications
      • 6.1.6.4.3.1. Forensics
      • 6.1.6.4.3.2. Agriculture
      • 6.1.6.4.3.3. Drug Development
      • 6.1.6.4.3.4. Others
      • 6.1.6.5. By End-users
      • 6.1.6.5.1. Hospitals and Healthcare Organizations
      • 6.1.6.5.2. Academics and Research Institutions
      • 6.1.6.5.3. Pharmaceutical and Biotechnology Companies
      • 6.1.6.5.4. Others
    • 6.1.7. Canada
    • 6.1.8. Mexico

All segments will be provided for all regions and countries covered:

  • 6.2. Europe
    • 6.2.1. Germany
    • 6.2.2. France
    • 6.2.3. Italy
    • 6.2.4. United Kingdom
    • 6.2.5. Russia
    • 6.2.6. Netherlands
    • 6.2.7. Spain
    • 6.2.8. Turkey
    • 6.2.9. Poland
  • 6.3. South America
    • 6.3.1. Brazil
    • 6.3.2. Argentina
  • 6.4. Asia-Pacific
    • 6.4.1. India
    • 6.4.2. China
    • 6.4.3. Japan
    • 6.4.4. Australia
    • 6.4.5. Vietnam
    • 6.4.6. South Korea
    • 6.4.7. Indonesia
    • 6.4.8. Philippines
  • 6.5. Middle East & Africa
    • 6.5.1. Saudi Arabia
    • 6.5.2. UAE
    • 6.5.3. South Africa

7. Market Mapping, 2023

  • 7.1. By Type
  • 7.2. By Technology
  • 7.3. By Application
  • 7.4. By End-users
  • 7.5. By Region

8. Macro Environment and Industry Structure

  • 8.1. Supply Demand Analysis
  • 8.2. Import Export Analysis - Volume and Value
  • 8.3. Supply/Value Chain Analysis
  • 8.4. PESTEL Analysis
    • 8.4.1. Political Factors
    • 8.4.2. Economic System
    • 8.4.3. Social Implications
    • 8.4.4. Technological Advancements
    • 8.4.5. Environmental Impacts
    • 8.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 8.5. Porter's Five Forces Analysis
    • 8.5.1. Supplier Power
    • 8.5.2. Buyer Power
    • 8.5.3. Substitution Threat
    • 8.5.4. Threat from New Entrant
    • 8.5.5. Competitive Rivalry

9. Market Dynamics

  • 9.1. Growth Drivers
  • 9.2. Growth Inhibitors (Challenges, Restraints)

10. Regulatory Framework and Innovation

  • 10.1. Clinical Trials
  • 10.2. Patent Landscape
  • 10.3. Regulatory Approvals
  • 10.4. Innovations/Emerging Technologies

11. Key Players Landscape

  • 11.1. Competition Matrix of Top Five Market Leaders
  • 11.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
  • 11.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 11.4. SWOT Analysis (For Five Market Players)
  • 11.5. Patent Analysis (If Applicable)

12. Pricing Analysis

13. Case Studies

14. Key Players Outlook

  • 14.1. Illumina, Inc.,
    • 14.1.1. Company Details
    • 14.1.2. Key Management Personnel
    • 14.1.3. Products & Services
    • 14.1.4. Financials (As reported)
    • 14.1.5. Key Market Focus & Geographical Presence
    • 14.1.6. Recent Developments
  • 14.2. Thermo-Fischer scientific
  • 14.3. BGI genomics
  • 14.4. Agilent Technologies Inc.
  • 14.5. 10X Genomics
  • 14.6. QIAGEN
  • 14.7. F. Hoffmann-La Roche Ltd
  • 14.8. Merck KGaA
  • 14.9. PerkinElmer Inc.
  • 14.10. Myriad Genetics Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

15. Strategic Recommendations

16. About Us & Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global DNA Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 2. Global DNA Sequencing Market, By Volume, In Millions, 2017-2031F
  • Figure 3. Global DNA Sequencing Market Share (%), By Product Type, 2017-2031F
  • Figure 4. Global DNA Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 5. Global DNA Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 6. Global DNA Sequencing Market Share (%), By End-users, 2017-2031F
  • Figure 7. Global DNA Sequencing Market Share (%), By Region, 2017-2031F
  • Figure 8. North America DNA Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 9. North America DNA Sequencing Market, By Volume, In Millions, 2017-2031F
  • Figure 10. North America DNA Sequencing Market Share (%), By Product Type, 2017-2031F
  • Figure 11. North America DNA Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 12. North America DNA Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 13. North America DNA Sequencing Market Share (%), By End-users, 2017-2031F
  • Figure 14. North America DNA Sequencing Market Share (%), By Country, 2017-2031F
  • Figure 15. United States DNA Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 16. United States DNA Sequencing Market, By Volume, In Millions, 2017-2031F
  • Figure 17. United States DNA Sequencing Market Share (%), By Product Type, 2017-2031F
  • Figure 18. United States DNA Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 19. United States DNA Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 20. United States DNA Sequencing Market Share (%), By End-users, 2017-2031F
  • Figure 21. Canada DNA Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 22. Canada DNA Sequencing Market, By Volume, In Millions, 2017-2031F
  • Figure 23. Canada DNA Sequencing Market Share (%), By Product Type, 2017-2031F
  • Figure 24. Canada DNA Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 25. Canada DNA Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 26. Canada DNA Sequencing Market Share (%), By End-users, 2017-2031F
  • Figure 27. Mexico DNA Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 28. Mexico DNA Sequencing Market, By Volume, In Millions, 2017-2031F
  • Figure 29. Mexico DNA Sequencing Market Share (%), By Product Type, 2017-2031F
  • Figure 30. Mexico DNA Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 31. Mexico DNA Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 32. Mexico DNA Sequencing Market Share (%), By End-users, 2017-2031F
  • Figure 33. Europe DNA Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 34. Europe DNA Sequencing Market, By Volume, In Millions, 2017-2031F
  • Figure 35. Europe DNA Sequencing Market Share (%), By Product Type, 2017-2031F
  • Figure 36. Europe DNA Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 37. Europe DNA Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 38. Europe DNA Sequencing Market Share (%), By End-users, 2017-2031F
  • Figure 39. Europe DNA Sequencing Market Share (%), By Country, 2017-2031F
  • Figure 40. Germany DNA Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 41. Germany DNA Sequencing Market, By Volume, In Millions, 2017-2031F
  • Figure 42. Germany DNA Sequencing Market Share (%), By Product Type, 2017-2031F
  • Figure 43. Germany DNA Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 44. Germany DNA Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 45. Germany DNA Sequencing Market Share (%), By End-users, 2017-2031F
  • Figure 46. France DNA Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 47. France DNA Sequencing Market, By Volume, In Millions, 2017-2031F
  • Figure 48. France DNA Sequencing Market Share (%), By Product Type, 2017-2031F
  • Figure 49. France DNA Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 50. France DNA Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 51. France DNA Sequencing Market Share (%), By End-users, 2017-2031F
  • Figure 52. Italy DNA Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 53. Italy DNA Sequencing Market, By Volume, In Millions, 2017-2031F
  • Figure 54. Italy DNA Sequencing Market Share (%), By Product Type, 2017-2031F
  • Figure 55. Italy DNA Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 56. Italy DNA Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 57. Italy DNA Sequencing Market Share (%), By End-users, 2017-2031F
  • Figure 58. United Kingdom DNA Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 59. United Kingdom DNA Sequencing Market, By Volume, In Millions, 2017-2031F
  • Figure 60. United Kingdom DNA Sequencing Market Share (%), By Product Type, 2017-2031F
  • Figure 61. United Kingdom DNA Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 62. United Kingdom DNA Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 63. United Kingdom DNA Sequencing Market Share (%), By End-users, 2017-2031F
  • Figure 64. Russia DNA Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 65. Russia DNA Sequencing Market, By Volume, In Millions, 2017-2031F
  • Figure 66. Russia DNA Sequencing Market Share (%), By Product Type, 2017-2031F
  • Figure 67. Russia DNA Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 68. Russia DNA Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 69. Russia DNA Sequencing Market Share (%), By End-users, 2017-2031F
  • Figure 70. Netherlands DNA Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 71. Netherlands DNA Sequencing Market, By Volume, In Millions, 2017-2031F
  • Figure 72. Netherlands DNA Sequencing Market Share (%), By Product Type, 2017-2031F
  • Figure 73. Netherlands DNA Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 74. Netherlands DNA Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 75. Netherlands DNA Sequencing Market Share (%), By End-users, 2017-2031F
  • Figure 76. Spain DNA Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 77. Spain DNA Sequencing Market, By Volume, In Millions, 2017-2031F
  • Figure 78. Spain DNA Sequencing Market Share (%), By Product Type, 2017-2031F
  • Figure 79. Spain DNA Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 80. Spain DNA Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 81. Spain DNA Sequencing Market Share (%), By End-users, 2017-2031F
  • Figure 82. Turkey DNA Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 83. Turkey DNA Sequencing Market, By Volume, In Millions, 2017-2031F
  • Figure 84. Turkey DNA Sequencing Market Share (%), By Product Type, 2017-2031F
  • Figure 85. Turkey DNA Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 86. Turkey DNA Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 87. Turkey DNA Sequencing Market Share (%), By End-users, 2017-2031F
  • Figure 88. Poland DNA Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 89. Poland DNA Sequencing Market, By Volume, In Millions, 2017-2031F
  • Figure 90. Poland DNA Sequencing Market Share (%), By Product Type, 2017-2031F
  • Figure 91. Poland DNA Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 92. Poland DNA Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 93. Poland DNA Sequencing Market Share (%), By End-users, 2017-2031F
  • Figure 94. South America DNA Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 95. South America DNA Sequencing Market, By Volume, In Millions, 2017-2031F
  • Figure 96. South America DNA Sequencing Market Share (%), By Product Type, 2017-2031F
  • Figure 97. South America DNA Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 98. South America DNA Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 99. South America DNA Sequencing Market Share (%), By End-users, 2017-2031F
  • Figure 100. South America DNA Sequencing Market Share (%), By Country, 2017-2031F
  • Figure 101. Brazil DNA Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 102. Brazil DNA Sequencing Market, By Volume, In Millions, 2017-2031F
  • Figure 103. Brazil DNA Sequencing Market Share (%), By Product Type, 2017-2031F
  • Figure 104. Brazil DNA Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 105. Brazil DNA Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 106. Brazil DNA Sequencing Market Share (%), By End-users, 2017-2031F
  • Figure 107. Argentina DNA Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 108. Argentina DNA Sequencing Market, By Volume, In Millions, 2017-2031F
  • Figure 109. Argentina DNA Sequencing Market Share (%), By Product Type, 2017-2031F
  • Figure 110. Argentina DNA Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 111. Argentina DNA Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 112. Argentina DNA Sequencing Market Share (%), By End-users, 2017-2031F
  • Figure 113. Asia-Pacific DNA Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 114. Asia-Pacific DNA Sequencing Market, By Volume, In Millions, 2017-2031F
  • Figure 115. Asia-Pacific DNA Sequencing Market Share (%), By Product Type, 2017-2031F
  • Figure 116. Asia-Pacific DNA Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 117. Asia-Pacific DNA Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 118. Asia-Pacific DNA Sequencing Market Share (%), By End-users, 2017-2031F
  • Figure 119. Asia-Pacific DNA Sequencing Market Share (%), By Country, 2017-2031F
  • Figure 120. India DNA Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 121. India DNA Sequencing Market, By Volume, In Millions, 2017-2031F
  • Figure 122. India DNA Sequencing Market Share (%), By Product Type, 2017-2031F
  • Figure 123. India DNA Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 124. India DNA Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 125. India DNA Sequencing Market Share (%), By End-users, 2017-2031F
  • Figure 126. China DNA Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 127. China DNA Sequencing Market, By Volume, In Millions, 2017-2031F
  • Figure 128. China DNA Sequencing Market Share (%), By Product Type, 2017-2031F
  • Figure 129. China DNA Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 130. China DNA Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 131. China DNA Sequencing Market Share (%), By End-users, 2017-2031F
  • Figure 132. Japan DNA Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 133. Japan DNA Sequencing Market, By Volume, In Millions, 2017-2031F
  • Figure 134. Japan DNA Sequencing Market Share (%), By Product Type, 2017-2031F
  • Figure 135. Japan DNA Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 136. Japan DNA Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 137. Japan DNA Sequencing Market Share (%), By End-users, 2017-2031F
  • Figure 138. Australia DNA Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 139. Australia DNA Sequencing Market, By Volume, In Millions, 2017-2031F
  • Figure 140. Australia DNA Sequencing Market Share (%), By Product Type, 2017-2031F
  • Figure 141. Australia DNA Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 142. Australia DNA Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 143. Australia DNA Sequencing Market Share (%), By End-users, 2017-2031F
  • Figure 144. Vietnam DNA Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 145. Vietnam DNA Sequencing Market, By Volume, In Millions, 2017-2031F
  • Figure 146. Vietnam DNA Sequencing Market Share (%), By Product Type, 2017-2031F
  • Figure 147. Vietnam DNA Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 148. Vietnam DNA Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 149. Vietnam DNA Sequencing Market Share (%), By End-users, 2017-2031F
  • Figure 150. South Korea DNA Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 151. South Korea DNA Sequencing Market, By Volume, In Millions, 2017-2031F
  • Figure 152. South Korea DNA Sequencing Market Share (%), By Product Type, 2017-2031F
  • Figure 153. South Korea DNA Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 154. South Korea DNA Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 155. South Korea DNA Sequencing Market Share (%), By End-users, 2017-2031F
  • Figure 156. Indonesia DNA Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 157. Indonesia DNA Sequencing Market, By Volume, In Millions, 2017-2031F
  • Figure 158. Indonesia DNA Sequencing Market Share (%), By Product Type, 2017-2031F
  • Figure 159. Indonesia DNA Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 160. Indonesia DNA Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 161. Indonesia DNA Sequencing Market Share (%), By End-users, 2017-2031F
  • Figure 162. Philippines DNA Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 163. Philippines DNA Sequencing Market, By Volume, In Millions, 2017-2031F
  • Figure 164. Philippines DNA Sequencing Market Share (%), By Product Type, 2017-2031F
  • Figure 165. Philippines DNA Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 166. Philippines DNA Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 167. Philippines DNA Sequencing Market Share (%), By End-users, 2017-2031F
  • Figure 168. Middle East & Africa DNA Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 169. Middle East & Africa DNA Sequencing Market, By Volume, In Millions, 2017-2031F
  • Figure 170. Middle East & Africa DNA Sequencing Market Share (%), By Product Type, 2017-2031F
  • Figure 171. Middle East & Africa DNA Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 172. Middle East & Africa DNA Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 173. Middle East & Africa DNA Sequencing Market Share (%), By End-users, 2017-2031F
  • Figure 174. Middle East & Africa DNA Sequencing Market Share (%), By Country, 2017-2031F
  • Figure 175. Saudi Arabia DNA Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 176. Saudi Arabia DNA Sequencing Market, By Volume, In Millions, 2017-2031F
  • Figure 177. Saudi Arabia DNA Sequencing Market Share (%), By Product Type, 2017-2031F
  • Figure 178. Saudi Arabia DNA Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 179. Saudi Arabia DNA Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 180. Saudi Arabia DNA Sequencing Market Share (%), By End-users, 2017-2031F
  • Figure 181. UAE DNA Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 182. UAE DNA Sequencing Market, By Volume, In Millions, 2017-2031F
  • Figure 183. UAE DNA Sequencing Market Share (%), By Product Type, 2017-2031F
  • Figure 184. UAE DNA Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 185. UAE DNA Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 186. UAE DNA Sequencing Market Share (%), By End-users, 2017-2031F
  • Figure 187. South Africa DNA Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 188. South Africa DNA Sequencing Market, By Volume, In Millions, 2017-2031F
  • Figure 189. South Africa DNA Sequencing Market Share (%), By Product Type, 2017-2031F
  • Figure 190. South Africa DNA Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 191. South Africa DNA Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 192. South Africa DNA Sequencing Market Share (%), By End-users, 2017-2031F
  • Figure 193. By Product Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 194. By Technology Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 195. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 196. By End-users Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 197. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023